ecancer

Symptom management and quality of life in metastatic breast cancer

Dr Polly Niravath - Baylor College of Medicine, Houston, Texas

20 Dec 2013

2013 ecancermedicalscience article highlights

Prof Gordon McVie - ecancer and European Institute of Oncology

11 Dec 2013

Pathology and diagnosis of nephroblastoma

Dr Gordan Vujanic – University of Cardiff, UK

27 Nov 2013

Engineering of polymeric nanoparticles for medical applications

Dr Omid Farokhzad - Harvard Medical School, Boston, USA

14 Nov 2013

Molecular imaging using PET-CT and personalised therapy with neuroendocrine tumours

Dr Harshad Kulkarni - Zentralklinik, Bad Berka, Germany

12 Nov 2013

The immune microenvironment as an anti-cancer therapeutic strategy

Dr Lisa Coussens - Oregon Science & Health University, USA

12 Nov 2013

SBRT in tumours of the spinal column

Dr Peter Gerszten - University of Pittsburgh, USA

15 Aug 2013

Editor’s Choice - ecancermedicalscience August 2013

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

8 Aug 2013

ECC 2013 Preview: Scientific programme highlights

Prof Vincenzo Valentini and Ian Banks

11 Jul 2013

Adding bevacizumab to standard first-line chemoradiation for glioblastoma gives no survival benefit

Prof Mark Gilbert - University of Texas MD Anderson Cancer Center, Houston, USA

6 Jun 2013

Science behind phase I clinical trials: targeting tumour cell development pathways

Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA

6 Jun 2013

No survival benefit to adding bevacizumab to standard first-line chemoradiation for glioblastoma

Dr Mark R. Gilbert - University of Texas MD Anderson Cancer Center, Houston, USA

2 Jun 2013

More from ecancer